Ginkgo biloba for mild memory problems with small vessel disease
Part of Mental health clinical trials.
This trial tests whether a natural extract from ginkgo biloba can help people with mild memory or thinking problems caused by small vessel disease in the brain. It looks for adults aged 50 to 75 who have had these symptoms for at least 3 months but can still live independently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 75 years old.
- Your brain MRI shows signs of small vessel disease (like white matter changes or small strokes).
- You have mild memory or thinking problems that have lasted at least 3 months, but you can still do daily activities on your own.
- You have not taken any medication for memory or thinking problems in the last 4 weeks.
- You do not have other brain diseases (like Alzheimer's, Parkinson's) or severe depression.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether Ginkgo biloba extract can improve blood markers and cognitive function in people with mild cognitive impairment (early memory loss). Researchers will measure changes in blood biomarkers to understand how Ginkgo may help protect brain health.
This trial studies EGb 761 to see if it can improve symptoms in people with mild cognitive impairment (early memory/thinking changes) who also have signs of brain blood vessel disease. It may help by targeting the brain changes seen on scans.
This study tests whether a special drink containing medium-chain triglycerides (MCTs, a type of fat) and B vitamins can help support memory and thinking in older adults with mild cognitive impairment (MCI). You would take the drink daily for 18 months and have regular check-ins including memory tests.
This trial studies a non-medication (non-drug) program to improve memory and daily thinking in people with mild cognitive impairment or mild Alzheimer’s disease. It may help by supporting brain function and monitoring symptoms over time.
This Phase 2 study tests whether the cholesterol medicine atorvastatin can improve how well blood vessels in the brain respond in people with mild cognitive impairment (MCI). It may help brain circulation and possibly slow thinking and memory problems.
This Phase 1 study tests whether Centella asiatica (a plant-based supplement) is safe and reaches its intended target in people with mild cognitive impairment or early Alzheimer’s disease. It also checks how it affects memory-related brain measures like MRI scans, which is why multiple scans are required.
Hear when a new Mild Cognitive Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.